MedPath

Carpal Tunnel Syndrome and Amyloidosis

Not Applicable
Conditions
Amyloidosis
Carpal Tunnel Syndrome
Interventions
Procedure: Carpal tunnel syndrome surgery
Registration Number
NCT04245098
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid.

Detailed Description

Carpal tunnel syndrome (CTS) can be caused by the deposition and accumulation of misfolded proteins called amyloid and is often an early manifestation of systemic amyloidosis.

Patients with cardiac amyloidosis often have carpal tunnel syndrome that precedes cardiac manifestations by several years, and many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand.

The investigators sought to identify the prevalence and type of amyloid deposits in patients undergoing carpal tunnel surgery and evaluate for cardiac involvement

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients undergoing carpal tunnel syndrome surgery
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AmyloidCarpal tunnel syndrome surgeryBiopsy
Primary Outcome Measures
NameTimeMethod
Number of participants with amyloid deposits in patients undergoing carpal tunnel surgery2 years

Prevalence of amyloid deposits in biopsy in patients undergoing carpal tunnel syndrome surgery

Secondary Outcome Measures
NameTimeMethod
Number of participants with cardiac involvement in echocardiogram2 years

Cardiac involment in echocardiography

Trial Locations

Locations (1)

Maria Del Carmen Navarro-Saez

🇪🇸

Sabadell, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath